This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Pl Wølner-Hanssen, MD; David Eschenbach, MD; Jorma Paavonen, MD; King K. Holmes, MD, PhD

JAMA. 1986;256(23):3262-3263.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Treatment of infertility is glamorous gynecology. Tubal microsurgery, embryo transfer, and in vitro fertilization are available only to women who can afford them. This multimillion-dollar high-technology medical industry is the impressive product of the science and practice of a growing body of specialists—membership in the American Fertility Society has increased from 5746 in 1976 to more than 10 000 in 1986.

Treatment of pelvic inflammatory disease (PID), the most important preventable cause of infertility, afflicting an estimated 1 million American women yearly, is not glamorous gynecology. In this issue of THE JOURNAL, Grimes et al¹ document the sorry state of affairs for what must be one of the most neglected areas of American medicine. Their analysis of data from a national survey of office-based private physicians shows that from 1966 through 1983, most women with suspected PID were treated on an outpatient basis and most received a single drug. . . . [Full Text PDF of this Article]

Author Affiliations
University of Washington School of Medicine Seattle

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?